Is Lexaria Bioscience Corp. (LEXX) Halal?
Shariah Screening — 5 Standards
Based on financial data from August 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 0.5% / 30% | 9.5% / 30% | 1.8% / 30% | 0.43% / 5% | ✓ HALAL |
| DJIM | 0.5% / 33% | 9.5% / 33% | 1.8% / 33% | 0.43% / 5% | ✓ HALAL |
| MSCI | 2.6% / 33% | 47.1% / 33% | 8.8% / 33% | 0.43% / 5% | ✗ NOT HALAL |
| S&P | 0.5% / 33% | 9.5% / 33% | 1.8% / 33% | 0.43% / 5% | ✓ HALAL |
| FTSE | 2.6% / 33% | 47.1% / 33% | 8.8% / 50% | 0.43% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 100.0% | |
| Operating Margin | -2014.6% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -155.2% | |
| Return on Assets (ROA) | -83.0% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$10M |
| Free Cash Flow | -$11M |
| Total Debt | $109,320 |
| Debt-to-Equity | 2.3 |
| Current Ratio | 3.7 |
| Total Assets | $4M |
Price & Trading
| Last Close | $0.75 |
| 50-Day MA | $0.72 |
| 200-Day MA | $0.89 |
| Avg Volume | 247K |
| Beta | 0.6 |
|
52-Week Range
$0.46
| |
About Lexaria Bioscience Corp. (LEXX)
Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods. Its DehydraTECH is used with a range of active molecules, including glucagon-like peptide-1 drugs (GLP-1) and glucose -dependent insulinotropic polypeptide drugs (GIP), vitamins, pain medications, hormones, phosphodiesterase type 5 (PDE5) inhibitors, antivirals, nicotine and its analogs, and cannabinoids. The company's DehydraTECH technology is applied to various therapeutic indications, such as diabetes, weight loss, hypertension, epilepsy, and heart disease; is implemented in a multitude of ingestible or topically administered product formats comprising oral suspensions, tablets, capsules, foods, beverages, and oral products; and is suitable for a variety of product formats, including pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The company was formerly known as Lexaria Corp. and changed its name to Lexaria Bioscience Corp. in April 2016. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.
Purification Calculator
As a halal stock with 0.43% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Lexaria Bioscience Corp. (LEXX) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Lexaria Bioscience Corp. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Lexaria Bioscience Corp.'s debt ratio?
Lexaria Bioscience Corp.'s debt ratio is 0.5% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 2.6%.
Does Lexaria Bioscience Corp. require dividend purification?
Yes, Lexaria Bioscience Corp. has an impermissible income ratio of 0.43%, which means 0.43% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are Lexaria Bioscience Corp.'s key financial metrics?
Lexaria Bioscience Corp. has a market capitalization of $18M, and revenue of $705,923. Return on equity stands at -155.2%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.